Novavax (NVAX) Cash from Investing Activities (2010 - 2026)

Novavax's Cash from Investing Activities history runs 17 years deep, the most recent figure standing at -$28.4 million for Q1 2026.

• In Q1 2026, Cash from Investing Activities rose 61.32% year-over-year to -$28.4 million; the TTM figure through Mar 2026 stood at -$33.3 million (up 87.67% YoY), while the FY2025 annual figure was -$78.3 million, up 61.64% from the prior year.
• Cash from Investing Activities was -$28.4 million for Q1 2026 at Novavax, down from $20.5 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $144.0 million in Q4 2024 to a low of -$372.7 million in Q2 2024.
• Historically, Cash from Investing Activities has averaged -$27.2 million across 5 years, with a median of -$18.4 million in 2023.
• Biggest YoY gain for Cash from Investing Activities was 1686.33% in 2024; the steepest drop was 4691.19% in 2024.
• A 5-year view of Cash from Investing Activities shows it stood at -$22.1 million in 2022, then surged by 58.86% to -$9.1 million in 2023, then soared by 1686.33% to $144.0 million in 2024, then sank by 85.78% to $20.5 million in 2025, then tumbled by 238.46% to -$28.4 million in 2026.
• The last three Cash from Investing Activities figures came in at -$28.4 million (Q1 2026), $20.5 million (Q4 2025), and -$136.5 million (Q3 2025), per Business Quant data.